login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
AKOYA BIOSCIENCES INC (AKYA) Stock News
NASDAQ:AKYA -
US00974H1041
-
Common Stock
1.29
USD
-0.07 (-5.15%)
Last: 7/7/2025, 8:00:00 PM
1.2899
USD
0 (-0.01%)
After Hours:
7/7/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AKYA Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: Benzinga
- Mentions:
INTS
RSLS
IMAB
CLNN
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
3 months ago - By: Kent Lake PR LLC
- Mentions:
QTRX
Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
4 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences Reports First Quarter 2025 Financial Results
3 months ago - By: Benzinga
- Mentions:
HCTI
JAGX
ABVC
APVO
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
4 months ago - By: Zacks Investment Research
- Mentions:
DTIL
Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates
4 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences Reports First Quarter 2025 Financial Results
4 months ago - By: Zacks Investment Research
- Mentions:
ACLX
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates
4 months ago - By: Kahn Swick & Foti, LLC
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
4 months ago - By: Zacks Investment Research
- Mentions:
ILMN
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
4 months ago - By: Quanterix Corporation
- Mentions:
QTRX
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
4 months ago - By: Halper Sadeh LLC
- Mentions:
PPBI
SSBK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PPBI, SSBK, AKYA on Behalf of Shareholders
4 months ago - By: Brodsky & Smith LLC
- Mentions:
PPBI
SSBK
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pacific Premier Bancorp, Inc. (Nasdaq - PPBI), Southern States Bancshares, Inc. (Nasdaq - SSBK), Akoya Biosciences, Inc. (Nasdaq - AKYA)
4 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
4 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
4 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
4 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
4 months ago - By: Halper Sadeh LLC
- Mentions:
BRDG
CKPT
QTRX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
5 months ago - By: Halper Sadeh LLC
- Mentions:
OPTN
SLRN
SHYF
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
5 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
5 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
5 months ago - By: Akoya Biosciences, Inc.
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
5 months ago - By: Akoya Biosciences, Inc.
- Mentions:
QTRX
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
7 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
7 months ago - By: Akoya Biosciences, Inc.
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
8 months ago - By: Halper Sadeh LLC
- Mentions:
SSTK
ACCD
ESSA
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
8 months ago - By: Kahn Swick & Foti, LLC
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
8 months ago - By: Ademi LLP
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders
8 months ago - By: Halper Sadeh LLC
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders
Please enable JavaScript to continue using this application.